Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Murray, Utah 25 trials found
New Search
Filter
Trial Phase
Study Type
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
PHASE2, PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
PHASE2, PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
PHASE1, PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
PHASE3INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
PHASE3INTERVENTIONAL Orange, California +4 more
RECRUITING
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
PHASE3INTERVENTIONAL Coral Springs, Florida +4 more
RECRUITING
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NAINTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
PHASE3INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
N/AOBSERVATIONAL Mesa, Arizona +4 more
RECRUITING
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Improving Health Insurance Literacy Among Young Adult Cancer Survivors
NAINTERVENTIONAL Murray, Utah +1 more
RECRUITING
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
PHASE1, PHASE2INTERVENTIONAL La Jolla, California +4 more
RECRUITING
A Study of MGC026 in Participants With Advanced Solid Tumors
PHASE1INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Phase 1/1b Study of IAM1363 in HER2 Cancers
PHASE1INTERVENTIONAL La Jolla, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type